Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1996 2
1998 2
2000 1
2003 5
2005 2
2006 3
2008 5
2009 4
2010 3
2011 8
2012 11
2013 6
2014 9
2015 10
2016 4
2017 12
2018 3
2019 6
2020 12
2021 11
2022 10
2023 11
2024 13
2025 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME Investigators. Zinman B, et al. N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17. N Engl J Med. 2015. PMID: 26378978 Free article. Clinical Trial.
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. Green JB, et al. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. N Engl J Med. 2015. PMID: 26052984 Free article. Clinical Trial.
Basal insulin and cardiovascular and other outcomes in dysglycemia.
ORIGIN Trial Investigators; Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S. ORIGIN Trial Investigators, et al. N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11. N Engl J Med. 2012. PMID: 22686416 Free article. Clinical Trial.
Strengthening the Family - the 'Five-I' Approach.
Kalra S, Saboo B, Cho NH, Sadikot S, Hasnani D, Chandarana H, Verma M, Bhandari S, Gupta A, Aravind SR. Kalra S, et al. Among authors: aravind sr. Eur Endocrinol. 2019 Apr;15(1):15-16. doi: 10.17925/EE.2019.15.1.15. Epub 2019 Apr 12. Eur Endocrinol. 2019. PMID: 31244905 Free PMC article.
Chitosan-based scaffolds as drug delivery systems in bone tissue engineering.
Bharathi R, Ganesh SS, Harini G, Vatsala K, Anushikaa R, Aravind S, Abinaya S, Selvamurugan N. Bharathi R, et al. Among authors: aravind s. Int J Biol Macromol. 2022 Dec 1;222(Pt A):132-153. doi: 10.1016/j.ijbiomac.2022.09.058. Epub 2022 Sep 13. Int J Biol Macromol. 2022. PMID: 36108752 Review.
Human Dirofilariasis- An Underrecognized Zoonosis.
Savithri V, Suresh R, Janardhanan M, Veeraraghavan R, Painatt JM, S AM, Aravind T, Mathew L. Savithri V, et al. Among authors: s am. Head Neck Pathol. 2025 Jul 14;19(1):88. doi: 10.1007/s12105-025-01826-7. Head Neck Pathol. 2025. PMID: 40658157
Management of metabolic dysfunction-associated steatotic liver disease (MASLD)-An expert consensus statement from Indian diabetologists' perspective.
Zargar AH, Bhansali A, Majumdar A, Maheshwari A, Bhattacharyya A, Dasgupta A, Saboo BD, Sethi BK, Sanyal D, Seshadri KG, Deshpande NR, Kapoor N, Lakhani OJ, Talwalkar PG, Kalra P, Mehrotra RN, Sahay RK, Shukla R, Kant S, Das S, Agarwal SC, Phatak SR, G S, Joshi SR, Shaikh SS, Aravind SR, Goswami S, Ghosh S, Panikar VK, Mohan V. Zargar AH, et al. Among authors: aravind sr. Diabetes Obes Metab. 2025 Jun;27 Suppl 4(Suppl 4):3-20. doi: 10.1111/dom.16496. Epub 2025 Jun 2. Diabetes Obes Metab. 2025. PMID: 40457532 Free PMC article. Review.
Ahmedabad declaration: A framework to combat growing epidemic of young-onset type 2 diabetes in Asia.
Parikh RM, Saboo B, Misra A, Basit A, Aravind SR, Bhowmik B, Schwarz P, Dhatariya K, Khunti K, Joshi S, Gupta S, Gupta A, Chawla M, Phatak S, Kalra S, Khan A, Mohan V; Ahmedabad Declaration Committee Members. Parikh RM, et al. Among authors: aravind sr. Diabetes Metab Syndr. 2025 Feb;19(2):103205. doi: 10.1016/j.dsx.2025.103205. Epub 2025 Feb 13. Diabetes Metab Syndr. 2025. PMID: 40054119 Free PMC article. Review.
Induction of pancreatic neoplasia in the KRAS/TP53 Oncopig.
Mondal P, Patel NS, Bailey K, Aravind S, Cartwright SB, Hollingsworth MA, Lazenby AJ, Carlson MA. Mondal P, et al. Among authors: aravind s. Dis Model Mech. 2023 Jan 1;16(1):dmm049699. doi: 10.1242/dmm.049699. Epub 2023 Jan 16. Dis Model Mech. 2023. PMID: 36579622 Free PMC article.
165 results